A practical guide for buprenorphine initiation in the primary care setting
Detailed description of how to start buprenorphine, including a description of a low-dose induction or overlapping start.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Detailed description of how to start buprenorphine, including a description of a low-dose induction or overlapping start.
This is an overview of resources that provide information about how medications can be used to treat substance use disorders and prevent overdose, including Food and Drug Administration (FDA)-approved medications for the treatment of alcohol use disorders.
These guidelines provide practical clinical practice-based guidance, based on available research combined with emerging clinical experience, on the use of buprenorphine in the treatment of individuals using fentanyl and other highly potent synthetic opioids.
Project ECHO provides online support and links expert specialist teams at an academic hub with primary care clinicians in local communities to help them implement evidence based practices.